Nachrichten zur Amgen Inc. Aktie

Amgen Appoints S. Omar Ishrak To Board Of Directors

THOUSAND OAKS, Calif., July 29, 2021 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced the appointment of S. Omar Ishrak to…

Amgen to pay up to $1.6 billion to acquire the privately held Teneobio

Shares of Amgen Inc. were down 0.1% in premarket trading on Wednesday, the day after the company announced that…

Amgen to acquire clinical stage biotechnology firm Teneobio

Biotechnology company Amgen has agreed to acquire Teneobio, a privately held clinical stage biotechnology firm, in a deal valued at…

Amgen to buy biotech company Teneobio in $900 million deal

Amgen Inc. agreed to buy biotechnology company Teneobio for a $900 million upfront cash payment, plus future contingent milestone payments…

Amgen To Acquire Teneobio For $900 Mln

THOUSAND OAKS (dpa-AFX) - Amgen Inc. (AMGN) Tuesday said it has agreed to buy Teneobio, a privately acquired company, for…

Amgen To Acquire Privately Held Teneobio For $900 Million In Cash With Future Contingent Milestone Payments

THOUSAND OAKS, Calif. and NEWARK, Calif., July 27, 2021 /PRNewswire/ -- Amgen (NASDAQ: AMGN) and Teneobio today announced an agreement…

Kyowa Kirin: Agreement With Amgen Points To A Blockbuster Drug

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Amgen-Backed Biotech Firm Hummingbird Weighing U.S. IPO

Amgen-Backed Biotech Firm Hummingbird Weighing U.S. IPO...…

deCODE genetics - New study on inheritance and fetal growth

REYKJAVIK, Iceland, July 19, 2021 /PRNewswire/ -- In a paper published in Nature genetics today, Scientists from deCODE genetics, a…

FDA Rebukes Amgen Over Misleading Branding Of Neulasta

Global Wearable Injectors Market Research Report 2021 Featuring Amgen, BD & Co., Enable Injections, Insulet, Ypsomed, Medtronic, Tandem Diabetes Care, Valeritas, West Pharma Services & Sensile Medical

DUBLIN, July 14, 2021 /PRNewswire/ -- The "Wearable Injectors Global Market Report 2021: COVID-19 Growth and Change to 2030" report…

Amgen: Undervalued Stock For Your Radar

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

AstraZeneca-Amgen drug gets FDA speedy review as asthma treatment

...(Reuters) -Drugmakers AstraZeneca and Amgen said on Thursday......…

UPDATE 1-AstraZeneca-Amgen drug gets FDA speedy review as asthma treatment

...(Adds executive comment, background) July 8 (Reuters) - Drugmakers......…

AstraZeneca receives US priority review for asthma candidate

AstraZeneca plc (LON:AZN) announced that an asthma treatment developed with Amgen has been granted priority review in the US. Tezepelumab…

Amgen: FDA Grants Priority Review For Tezepelumab In Treatment Of Asthma

THOUSAND OAKS (dpa-AFX) - Amgen (AMGN) said that the U.S. Food and Drug Administration has accepted a Biologics License Application…

Tezepelumab Granted Priority Review By U.S. FDA

THOUSAND OAKS, Calif., July 7, 2021 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA)…

Why Amgen Is A Top 25 Dividend Giant

Amgen has been named as a Top 25 Dividend Giant by ETF Channel, with a whopping $20.37B worth of stock…

The Zacks Analyst Blog Highlights: Google, Visa, Eli Lilly, Amgen and Sony Group

The Zacks Analyst Blog Highlights: Google, Visa, Eli Lilly, Amgen and Sony Group...…

Amgen Pumps $365M Into New Ohio Facility

Amgen: A Defensive Play In An Expensive Market

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Amgen: Aimovig Approved In Japan To Suppress Onset Of Migraine Attacks In Adults

THOUSAND OAKS (dpa-AFX) - Amgen (AMGN) announced Wednesday that the Japanese Ministry of Health, Labour and Welfare has granted marketing…

Amgen Announces Approval Of Aimovig® (Erenumab) In Japan For The Suppression Of Onset Of Migraine Attacks In Adults

THOUSAND OAKS, Calif., June 23, 2021 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the Japanese Ministry of Health, Labour and…

Global Regenerative Medicine Market Outlook 2021-2026: Major Players are Amgen, Bristol Myers Squibb, Dendreon, F. Hoffmann-La Roche, Gilead Sciences, Novartis, Osiris, Organogenesis, and Vericel

DUBLIN, June 18, 2021 /PRNewswire/ -- The "Regenerative Medicine Market - Global Outlook and Forecast 2021-2026" report has been added…

A New Cancer Treatment. Cracking The KRAS Code

The recent approval of Lumakras (Amgen, AMG 510) by the US Food and Drug Administration as a treatment for non-small…

Umfrage von Amgen belegt Imageschub für Pharma-Unternehmen

Bildnachweis: ASDF – stock.adobe.com. Das Ansehen von Pharma-Unternehmen ist in den vergangenen drei Jahren deutlich gestiegen. So schreiben neun von…

Amgen Inc. (AMGN) Management Presents at Goldman Sachs 42nd Annual Global Healthcare Conference (Transcript)

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Amgen: Kursziel angehoben

New York (www.aktiencheck.de) - Rating-Update: Jay Olson, Analyst von Oppenheimer, stuft die Aktie des Biotechkonzerns Amgen Inc. (ISIN: US0311621009, WKN:…

Amgen: Kursziel erhöht

Boston (www.aktiencheck.de) - Rating-Update: Geoffrey Porges, Analyst von SVB Leerink, stuft die Aktie des Biotechkonzerns Amgen Inc. (ISIN: US0311621009, WKN:…

Amgen To Present At The Goldman Sachs 42nd Annual Global Healthcare Conference

THOUSAND OAKS, Calif., June 4, 2021 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the Goldman Sachs 42nd Annual Global Healthcare…

Results From Phase 2 CodeBreaK 100 Show LUMAKRAS™ (sotorasib) Is The First And Only KRAS G12C Inhibitor With Overall Survival Data

THOUSAND OAKS, Calif., June 4, 2021 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today presented data on overall survival, a secondary endpoint,…

Amgen Says Follow-up Phase 2 FIGHT Trial Data Shows Improved OS

THOUSAND OAKS (dpa-AFX) - Amgen, Inc. (AMGN) announced on Friday updated results for investigational bemarituzumab in combination with chemotherapy from…

Amgen, Inc. (AMGN) Presents at Jefferies Healthcare Broker Conference Call - (Transcript)

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Dow up 88 points on gains for shares of Visa, Amgen Inc.

Dow up 88 points on gains for shares of Visa, Amgen Inc....…

Amgen Stock Set To Rise After Lumakras Approval

The stock price of Amgen (NASDAQ: AMGN) has seen a 5% drop over the last five trading days. The decline…

Amgen, Kyowa Kirin partner to develop antibody for atopic dermatitis

Amgen has signed an agreement with Japanese pharmaceutical firm Kyowa Kirin to jointly develop and commercialise Phase III-ready antibody for…

Amgen: Lumakras And Tezepelumab Deep Dive

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Amgen to Webcast Investor Meeting at ASCO 2021

THOUSAND OAKS, Calif., June 1, 2021 /PRNewswire/ -- Amgen (NASDAQ: AMGN) will host a webcast call for the investment community…

Amgen (AMGN) Inks Deal With Kyowa Kirin to Develop AD Treatment

Amgen (AMGN) inks an agreement with Kyowa Kirin Co. to develop and commercialize the latters KHK4083, which is being developed…

Amgen: Kurszielanhebung

Toronto (www.aktiencheck.de) - Rating-Update: Do Kim, Analyst von BMO Capital Markets, stuft die Aktie des Biotechkonzerns Amgen Inc. (ISIN: US0311621009,…

Amgen and Kyowa Kirin in pact for experimental atopic dermatitis therapy

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Amgen, Kyowa Kirin To Jointly Develop, Commercialize KHK4083

THOUSAND OAKS (dpa-AFX) - Amgen (AMGN) announced an agreement with Kyowa Kirin Co., Ltd. to jointly develop and commercialize KHK4083,…

Amgen and Kyowa Kirin to Jointly Develop and Commercialize KHK4083, a Phase 3-Ready, Potential First-In-Class Treatment for Atopic Dermatitis

Agreement Renews Successful Global Collaboration That led to Several Groundbreaking Therapies in Multiple Disease Areas KHK4083 Depletes OX40-Expressing T cells…